Welcome to our dedicated page for United Guardian SEC filings (Ticker: UG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The United-Guardian, Inc. (NASDAQ: UG) SEC filings page brings together the company’s regulatory disclosures, including annual, quarterly, and current reports filed with the U.S. Securities and Exchange Commission. These documents provide detailed information on United-Guardian’s operations as a manufacturer of cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness ingredients.
In its periodic reports, such as Form 10-K and Form 10-Q, United-Guardian presents financial statements that break out net sales, cost of sales, operating expenses, and research and development expense. Investors can see how revenue and profitability relate to the company’s four main product categories and review line items such as investment income and gains or losses on marketable securities. These filings also discuss factors that influence results, including distributor demand and supply conditions for key products like Renacidin.
Form 8-K current reports are used by United-Guardian to furnish press releases on results of operations and financial condition and to provide Regulation FD disclosures for events such as dividend declarations. Recent 8-K filings reference attached press releases that describe quarterly performance and Board decisions on cash dividends.
On this page, AI-powered tools can help interpret lengthy filings by highlighting key sections, summarizing changes in sales and expenses, and clarifying the significance of items such as research and development spending or other income. Users can quickly locate references to product categories, dividend policies, and projects related to Renacidin and personal care products, while real-time updates ensure that new United-Guardian filings from EDGAR are available as they are submitted.